Aprea Therapeutics, Inc.
APRE
DELAYED 1 MONTH

2 insider filings · Latest: Mar 12, 2026

Common Stock Transactions

No transactions found.

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Mar 12, 2026Mar 16 10:07 PMOren GiladDirector, President/CEO
Grant/Award
80,700$0.76580,700(D)

View →

Mar 12, 2026Mar 16 10:06 PMJohn P. HamillSrVP/CFO/Prin Fin & Acct Ofcr
Grant/Award
40,380$0.76540,380(D)

View →